Viewing Study NCT00551850


Ignite Creation Date: 2025-12-24 @ 4:54 PM
Ignite Modification Date: 2026-02-25 @ 11:01 PM
Study NCT ID: NCT00551850
Status: COMPLETED
Last Update Posted: 2011-10-04
First Post: 2007-10-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Safety Study of an Oral EGFR Inhibitor, AV-412, Administered Three Times Weekly in Advanced Solid Tumor Patients
Sponsor: AVEO Pharmaceuticals, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Cancer View
None Refractory Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None epidermal growth factor inhibitor View
None solid tumors View
None advanced cancer View